Harneys advises Cuprina Holdings (Cayman) Ltd. on NASDAQ listing
Cuprina is a Singapore-based biomedical and biotechnology company dedicated to the development and commercialisation of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector.
The Harneys team was led by Singapore Managing Partner Lishi Fong with support from Senior Associate Jonathan Lim and Associate Edwin Tan. R. F. Lafferty & Co., Inc. acted as the sole book-running manager for the Offering. Loeb & Loeb LLP and Lee & Lee acted as US and Singapore legal counsel to the Company, respectively, while Winston & Strawn LLP served as US legal counsel to R. F. Lafferty for the offering.
Lishi commented: “We are delighted and honoured to support our client Cuprina Holdings on their successful public offering and Nasdaq listing. This achievement highlights our team’s deep expertise in handling complex cross-border transactions and our commitment to delivering exceptional results for our clients. We look forward to continuing to assist clients in achieving their strategic goals in the global financial markets.”
The Corporate team at Harneys has a leading Equity Capital Markets (ECM) practice with substantial experience in all aspects of capital raising by offshore companies, including reverse mergers, IPOs and secondary offerings, rights issues, equity linked securities, including convertible and exchangeable bonds, SPACs, and business combinations, as well as private placements, take-privates, takeovers, and spin-offs. The firm’s ECM expertise lies in advising entities listed or listing on all major stock exchanges, including the New York Stock Exchange, NASDAQ, the London Stock Exchange, AIM, the Hong Kong Stock Exchange, the Shanghai Stock Exchange, the Luxembourg Stock Exchange, and the Singapore Stock Exchange.
